IL-17A: A promising target in viral lung infections

Anders Lindén

doi:10.1111/resp.14158

IL-17A: A promising target in viral lung infections

Respirology. 2021 Nov;26(11):1012-1013. doi: 10.1111/resp.14158. Epub 2021 Sep 27.

Author

Anders Lindén^{1

2}

Affiliations

¹ Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.
² Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.

PMID: 34580948
DOI: 10.1111/resp.14158

No abstract available

Keywords: influenza; lymphocyte; monoclonal antibody; neutrophil; respiratory syncytial virus; rhinovirus; therapy for viral lung infections IL-17.

Publication types

Editorial
Comment

MeSH terms

Humans
Interleukin-17
Lung
Respiratory Syncytial Virus Infections*
Respiratory Syncytial Viruses
Virus Diseases*

Substances

Interleukin-17